Thomas Steuber

11.3k total citations · 1 hit paper
210 papers, 6.5k citations indexed

About

Thomas Steuber is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, Thomas Steuber has authored 210 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 188 papers in Pulmonary and Respiratory Medicine, 50 papers in Rheumatology and 34 papers in Oncology. Recurrent topics in Thomas Steuber's work include Prostate Cancer Treatment and Research (164 papers), Prostate Cancer Diagnosis and Treatment (146 papers) and Urologic and reproductive health conditions (46 papers). Thomas Steuber is often cited by papers focused on Prostate Cancer Treatment and Research (164 papers), Prostate Cancer Diagnosis and Treatment (146 papers) and Urologic and reproductive health conditions (46 papers). Thomas Steuber collaborates with scholars based in Germany, Canada and Italy. Thomas Steuber's co-authors include Markus Graefen, Hartwig Huland, Alexander Haese, Thorsten Schlomm, Hans Heinzer, Georg Salomon, Felix K.‐H. Chun, Lars Budäus, Pierre I. Karakiewicz and Andreas Erbersdobler and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Thomas Steuber

193 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy

2015 337 citations Lars Budäus, Georg Salomon et al. European Urology profile →

Peers

Countries citing papers authored by Thomas Steuber

Since Specialization

Citations

This map shows the geographic impact of Thomas Steuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Steuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Steuber more than expected).

Fields of papers citing papers by Thomas Steuber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Steuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Steuber. The network helps show where Thomas Steuber may publish in the future.

Co-authorship network of co-authors of Thomas Steuber

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Steuber. A scholar is included among the top collaborators of Thomas Steuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Steuber. Thomas Steuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of peritoneal bladder flap in robot-assisted radical prostatectomy patients on lymphoceles: a prospective randomised trial 2025 ·World Journal of Urology ·(unknown), Sophie Knipper, Burkhard Beyer, (unknown), (unknown), Hans Heinzer, Georg Salomon, Thomas Steuber, (unknown), Derya Tilki, Hendrik Isbarn, Tobias Maurer, Pierre Tennstedt, (unknown), Uwe Michl	0
2	Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancer 2024 ·JBMR Plus ·Mike Wenzel, Benedikt Hoeh, Clara Humke, (unknown), Cristina Cano Garcia, Carolin Siech, Fred Saad, (unknown), Derya Tilki, Thomas Steuber, (unknown), (unknown), (unknown), Philipp Mandel	0
3	Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer 2024 ·World Journal of Urology ·Mike Wenzel, Benedikt Hoeh, Clara Humke, Cristina Cano Garcia, Carolin Siech, Thomas Steuber, (unknown), (unknown), Luis Kluth, Felix K.‐H. Chun, Philipp Mandel	0
4	Robot-assisted vs open retropubic radical prostatectomy: a propensity score-matched comparative analysis based on 15 years and 18,805 patients 2024 ·World Journal of Urology ·Francesca Ambrosini, Sophie Knipper, Derya Tilki, Hans Heinzer, Georg Salomon, Uwe Michl, Thomas Steuber, (unknown), Lars Budäus, Tobias Maurer, Carlo Terrone, Pierre Tennstedt, Markus Graefen, Alexander Haese	5
5	Comparative analysis of robot-assisted and open approach for PSMA-radioguided surgery in recurrent prostate cancer 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Francesca Ambrosini, Fabian Falkenbach, Lars Budäus, Thomas Steuber, Markus Graefen, Daniel Köehler, Sophie Knipper, Tobias Maurer	4
6	A Neural Network Model Combining [-2]proPSA, freePSA, Total PSA, Cathepsin D, and Thrombospondin-1 Showed Increased Accuracy in the Identification of Clinically Significant Prostate Cancer 2023 ·Cancers ·Francesco Gentile, Evelina La Civita, Bartolomeo Della Ventura, Matteo Ferro, Dario Bruzzese, Felice Crocetto, Pierre Tennstedt, Thomas Steuber, Raffaele Velotta, Daniela Terracciano	11
7	Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical Prostatectomy 2023 ·Medicina ·Cristina Cano Garcia, Mike Wenzel, Clara Humke, (unknown), (unknown), Reha‐Baris Incesu, Jens Köllermann, Thomas Steuber, Markus Graefen, Derya Tilki, Pierre I. Karakiewicz, Luis A. Kluth, Felix Preißer, Felix K.‐H. Chun, Philipp Mandel, Benedikt Hoeh	6
8	Androgendeprivationstherapie und kardiovaskuläre Morbidität beim Prostatakarzinom: ein narratives Review 2023 ·PubMed ·Jakob Klemm, Markus von Deimling, Margit Fisch, Gero Kramer, Derya Tilki, Thomas Steuber, Gunhild von Amsberg, Christian Hengstenberg, Shahrokh F. Shariat	0
9	PD27-05 IMPACT OF PERITONEAL BLADDER FLAP ON THE RISK OF SYMPTOMATIC LYMPHOCELES AFTER ROBOTIC RADICAL PROSTATECTOMY: RESULTS OF A PROSPECTIVE RANDOMISED-CONTROLLED TRIAL 2023 ·The Journal of Urology ·(unknown), Sophie Knipper, Lukas Hohenhorst, Burkhard Beyer, Derya Tilki, Alexander Haese, Hans Heinzer, Georg Salomon, Thomas Steuber, Lars Budäus, Hendrik Isbarn, Tobias Maurer, Pierre Tennstedt, Markus Graefen, Uwe Michl	1
10	New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index 2022 ·The Prostate ·Daniela Terracciano, Evelina La Civita, (unknown), Antonietta Liotti, (unknown), Michele Cennamo, Felice Crocetto, Pierre Tennstedt, Ralph Schiess, Alexander Haese, Matteo Ferro, Thomas Steuber	16
11	Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review 2021 ·World Journal of Urology ·Gaëtan Devos, (unknown), Gert De Meerleer, (unknown), Wout Devlies, Frank Claessens, Markus Graefen, Thomas Steuber, Alberto Briganti, Alexandre de la Taille, Hendrik Van Poppel, Steven Joniau	8
12	Safety of long-term (LT) treatment (tmt) of chemotherapy (chemo)-naïve metastatic castration-resistant prostate cancer (mCRPC) patients (pts) with abiraterone acetate plus prednisone (AA + P) for ≥ 4 years (yrs) 2016 ·Annals of Oncology ·Joan Carles, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Winald R. Gerritsen, Dana E. Rathkopf, Charles J. Ryan, Fred Saad, Thomas Steuber, George Wilding, (unknown), Robert L. Charnas, Peter De Porre, Hendrik Van Poppel	1
13	Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validation 2015 ·Urologic Oncology Seminars and Original Investigations ·Jens Hansen, Andreas Becker, Luis A. Kluth, Michael Rink, Thomas Steuber, Margit Zacharias, Alberto Briganti, Margit Fisch, Markus Graefen, Felix K.‐H. Chun	5
14	Aktuelle Ergebnisse zur PSA-basierten Früherkennung des Prostatakarzinoms 2014 ·Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz ·Markus Graefen, Thorsten Schlomm, Thomas Steuber, Guido Sauter	1
15	CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer 2013 ·Cancer Research ·Lia Burkhardt, (unknown), Antje Krohn, Sawinee Masser, Malte Mäder, Martina Kluth, (unknown), Hartwig Huland, Thomas Steuber, Markus Graefen, Thorsten Schlomm, Sarah Minner, Guido Sauter, Hüseyin Sirma, Ronald Simon	130
16	Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer 2010 ·Clinical Cancer Research ·Sarah Minner, (unknown), (unknown), Eike Burandt, Jens Köllermann, Martina Mirlacher, Andreas Erbersdobler, Christian Eichelberg, Margit Fisch, Tim H. Brümmendorf, Carsten Bokemeyer, Ronald Simon, Thomas Steuber, Markus Graefen, Hartwig Huland, Guido Sauter, Thorsten Schlomm	110
17	Contemporary Prostate Cancer Prevalence among T1c Biopsy-Referred Men with a Prostate-Specific Antigen Level ≤ 4.0ng per Milliliter 2007 ·European Urology ·Sascha Ahyai, Markus Graefen, Thomas Steuber, Alexander Haese, Thorsten Schlomm, Jochen Walz, Jens Köllermann, Alberto Briganti, Margit Zacharias, Martin Friedrich, Pierre I. Karakiewicz, Francesco Montorsi, Hartwig Huland, Felix K.‐H. Chun	22
18	Einfluß der PSA-Bestimmung auf Diagnostik und Therapie des Prostatakarzinoms - eine aktuelle Standortbestimmung 2006 ·Journal für Kardiologie (Krause & Pachernegg GmbH) ·Thomas Steuber, Markus Graefen, Hartwig Huland	2
19	Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue 2004 ·The Prostate ·Thomas Steuber, (unknown), Alexander Haese, Kim Pettersson, Andreas Erbersdobler, (unknown), Markus Graefen, Michael W. Kattan, Hartwig Huland, Hans Lilja	27
20	Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146 2002 ·Oxford University Research Archive (ORA) (University of Oxford) ·(unknown), Thomas Steuber, Alexander Haese, Kim Pettersson, P. Hammerer, (unknown), Hans Lilja	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact